Adial Pharmaceuticals, Inc (ADIL) Total Assets by Year
Adial Pharmaceuticals, Inc closed fiscal year 2025 with $6.7M in total assets, $1.4M in total liabilities and $5.3M in shareholder equity. This represents an increase of 32.3% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Adial Pharmaceuticals, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADIL Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.7M+32.3% | $5.0M+6.5% | $4.7M-17.4% | $5.7M-23.3% | $7.5M+36.1% | $5.5M-28.5% | $7.7M+63.4% | $4.7M+13503.0% | $35K |
| Total Liabilities | $1.4M+43.2% | $976K+49.4% | $653K-73.4% | $2.5M-38.1% | $4.0M+163.5% | $1.5M+179.3% | $539K+109.0% | $258K-75.0% | $1.0M |
| Total Equity | $5.3M+29.7% | $4.1M-0.4% | $4.1M+24.6% | $3.3M-6.6% | $3.5M-12.0% | $4.0M-44.2% | $7.1M+60.8% | $4.4M+545.2% | -$998K |
ADIL Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.1M+327.7% | $5.2M+51.5% | $6.7M+32.3% | $5.7M-15.7% | $6.8M+37.4% | $3.5M | $5.0M+6.5% | $6.7M+134.1% | $4.9M+31.0% | N/A | $4.7M-17.4% | $2.9M-63.0% |
| Total Liabilities | $67.5M+5471.0% | $1.5M+14.0% | $1.4M+43.2% | $1.2M+39.3% | $1.2M+80.2% | $1.3M | $976K+49.4% | $829K+57.0% | $672K+45.5% | N/A | $653K-73.4% | $528K-77.4% |
| Total Equity | -$38.4M-786.5% | $3.7M+74.8% | $5.3M+29.7% | $4.5M-23.4% | $5.6M+30.7% | $2.1M-65.3% | $4.1M-0.4% | $5.9M+151.5% | $4.3M+28.9% | $6.1M+325.2% | $4.1M+24.6% | $2.3M-56.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Adial Pharmaceuticals, Inc financials
Frequently Asked Questions
What was Adial Pharmaceuticals, Inc's total assets in fiscal year 2025?
Adial Pharmaceuticals, Inc closed fiscal year 2025 with $6.7M in total assets, $1.4M in total liabilities and $5.3M in shareholder equity.
How fast is Adial Pharmaceuticals, Inc's total assets growing?
Adial Pharmaceuticals, Inc (ADIL) total assets rose by 32.3% year over year, from $5.0M to $6.7M in fiscal year 2025.
How has Adial Pharmaceuticals, Inc's total assets changed over the years?
Across the 9 fiscal years this page covers, Adial Pharmaceuticals, Inc (ADIL) total assets went from $35K in fiscal year 2017 to $6.7M in fiscal year 2025.
What was Adial Pharmaceuticals, Inc's total assets in the most recent quarter?
Adial Pharmaceuticals, Inc (ADIL) reported $29.1M in total assets in Q2 2026. This represents an increase of 327.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Adial Pharmaceuticals, Inc (ADIL) reported on that line in every period on record.